Plain-English translation of NCT05744219 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
After major surgery like liver, pancreas, or aortic surgery, many patients develop anemia (low blood levels) because of blood loss during the operation. This trial is testing whether a single infusion of , an iron medication, can help your body recover faster and reduce the need for blood transfusions after surgery.
When you lose blood during major surgery, your body needs to rebuild its red blood cells quickly. Since iron is essential for making new blood cells, researchers believe that giving iron directly into the bloodstream after surgery might speed up recovery and help you feel better sooner.
You likely qualify if…
You likely don't qualify if…
You will have your scheduled surgery as planned. If you lose the right amount of blood during surgery, you will randomly receive either one infusion of iron medication or a placebo (salt water) before you leave the operating room. Over the next five weeks, you will have follow-up visits where doctors check your blood levels, energy, and overall recovery, and ask about your quality of life.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Sweden
Large-scale testing
Sponsor
Jon Unosson
Enrollment target
~338 participants
Started
September 2024
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jon Unosson, MDPhD
Jon Unosson
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.